| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CFO
1 company
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $80.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $9.72 | $19,440.00 | - | +46.9% | -7.7% | |
| Sep 30, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,000 | $9.46 | $9,460.00 | - | +67.8% | -2.9% | |
| Sep 29, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,000 | $9.23 | $9,230.00 | - | +78.2% | -6.7% | |
| Jun 24, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 29,000 | $9.13 | $264,770.00 | +0.5% | +8.5% | +13.8% | |
| Jun 16, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 8,000 | $7.13 | $57,040.00 | +0.3% | +35.7% | +52.7% | |
| Jun 14, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 12,000 | $7.91 | $94,920.00 | +0.5% | +31.1% | +41.9% | |
| Jun 10, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 12,000 | $8.33 | $99,960.00 | +0.5% | +12.3% | +30.6% | |
| Jun 9, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 4,500 | $10.90 | $49,050.00 | +0.4% | -16.6% | +3.6% | |
| Jun 7, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 6,000 | $8.55 | $51,300.00 | +0.5% | +0.8% | +34.2% | |
| Jun 3, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 9,250 | $8.35 | $77,237.50 | +0.8% | -2.7% | +21.8% |